Susan Hadley

11.8k total citations · 1 hit paper
44 papers, 4.3k citations indexed

About

Susan Hadley is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Susan Hadley has authored 44 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 21 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Susan Hadley's work include Antifungal resistance and susceptibility (23 papers), Fungal Infections and Studies (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Susan Hadley is often cited by papers focused on Antifungal resistance and susceptibility (23 papers), Fungal Infections and Studies (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Susan Hadley collaborates with scholars based in United States, France and United Kingdom. Susan Hadley's co-authors include Kieren A. Marr, Thomas J. Walsh, Thomas F. Patterson, Dimitrios P. Kontoyiannis, Vicki A. Morrison, M. Hong Nguyen, Raoul Herbrecht, David W. Denning, Jo‐Anne H. Young and John E. Bennett and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Susan Hadley

44 papers receiving 4.2k citations

Hit Papers

Practice Guidelines for the Diagnosis and Management of A... 2016 2026 2019 2022 2016 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Hadley United States 28 3.4k 2.9k 483 366 320 44 4.3k
Robert Krause Austria 41 3.2k 0.9× 3.0k 1.0× 539 1.1× 286 0.8× 308 1.0× 164 5.4k
John F. Fisher United States 22 3.5k 1.0× 3.0k 1.1× 374 0.8× 206 0.6× 299 0.9× 46 4.5k
Michél Laverdière Canada 34 3.3k 1.0× 2.9k 1.0× 327 0.7× 392 1.1× 430 1.3× 103 4.4k
Dionysios Neofytos Switzerland 30 3.4k 1.0× 3.2k 1.1× 271 0.6× 277 0.8× 227 0.7× 120 4.5k
Haran T. Schlamm United States 27 2.4k 0.7× 2.1k 0.7× 335 0.7× 300 0.8× 254 0.8× 46 3.8k
Christine C. Chiou United States 21 2.8k 0.8× 3.0k 1.1× 257 0.5× 363 1.0× 443 1.4× 38 4.2k
P. M. Shah Germany 22 2.0k 0.6× 2.2k 0.8× 289 0.6× 298 0.8× 561 1.8× 103 3.7k
Hiroshi Kakeya Japan 31 1.9k 0.6× 1.9k 0.7× 435 0.9× 210 0.6× 262 0.8× 253 3.5k
G. Petrikkos Greece 35 3.5k 1.0× 3.1k 1.1× 166 0.3× 384 1.0× 871 2.7× 100 5.3k
Melissa D. Johnson United States 29 2.1k 0.6× 1.9k 0.7× 194 0.4× 155 0.4× 256 0.8× 92 3.3k

Countries citing papers authored by Susan Hadley

Since Specialization
Citations

This map shows the geographic impact of Susan Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Hadley more than expected).

Fields of papers citing papers by Susan Hadley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Hadley. The network helps show where Susan Hadley may publish in the future.

Co-authorship network of co-authors of Susan Hadley

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Hadley. A scholar is included among the top collaborators of Susan Hadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Hadley. Susan Hadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poutsiaka, Debra D., Jana Hudcova, David J. Tybor, et al.. (2019). Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill Patients. Open Forum Infectious Diseases. 6(7). ofz271–ofz271. 14 indexed citations
3.
Chow, Jennifer, György Frendl, Susan Hadley, et al.. (2010). Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?. Journal of Antimicrobial Chemotherapy. 65(7). 1460–1465. 82 indexed citations
4.
Ostrosky‐Zeichner, Luis, Bart Jan Kullberg, Eric J. Bow, et al.. (2010). Early treatment of candidemia in adults: a review. Medical Mycology. 49(2). 113–120. 79 indexed citations
5.
Hadley, Susan, Peter G. Pappas, Jennifer S. Daly, et al.. (2008). Outcomes of antifungal prophylaxis in high‐risk liver transplant recipients. Transplant Infectious Disease. 11(1). 40–48. 40 indexed citations
6.
Chow, Jennifer, Yoav Golan, Robin Ruthazer, et al.. (2008). Risk factors for albicans and non-albicans candidemia in the intensive care unit*. Critical Care Medicine. 36(7). 1993–1998. 108 indexed citations
7.
Chow, Jennifer, Yoav Golan, Robin Ruthazer, et al.. (2008). Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit. Clinical Infectious Diseases. 46(8). 1206–1213. 180 indexed citations
8.
Kligler, Benjamin, Mary Koithan, Victoria Maizes, et al.. (2007). Competency-based evaluation tools for integrative medicine training in family medicine residency: a pilot study. BMC Medical Education. 7(1). 7–7. 34 indexed citations
9.
Drees, Marci, Brian L. Wickes, Mamta Gupta, & Susan Hadley. (2007). Lecythophora mutabilisprosthetic valve endocarditis in a diabetic patient. Medical Mycology. 45(5). 463–467. 13 indexed citations
10.
Pappas, Peter G., David R. Andes, Mindy G. Schuster, et al.. (2006). Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study. American Journal of Transplantation. 6(2). 386–391. 78 indexed citations
11.
Raad, Issam, John R. Graybill, Oliver A. Cornely, et al.. (2006). Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections. Clinical Infectious Diseases. 42(12). 1726–1734. 165 indexed citations
12.
Kohli, Rakhi & Susan Hadley. (2005). Fungal Arthritis and Osteomyelitis. Infectious Disease Clinics of North America. 19(4). 831–851. 64 indexed citations
13.
Magiorakos, Anna-Pelagia & Susan Hadley. (2004). Impact of real-time fungal susceptibility on clinical practices. Current Opinion in Infectious Diseases. 17(6). 511–515. 6 indexed citations
14.
Muñoz-Price, L. Silvia, Malcolm Slifkin, Robin Ruthazer, et al.. (2004). The Clinical Impact of Ganciclovir Prophylaxis on the Occurrence of Bacteremia in Orthotopic Liver Transplant Recipients. Clinical Infectious Diseases. 39(9). 1293–1299. 53 indexed citations
15.
Doron, Shira, John F. Dashe, Lester S. Adelman, et al.. (2003). Histopathologically Proven Poliomyelitis with Quadriplegia and Loss of Brainstem Function Due to West Nile Virus Infection. Clinical Infectious Diseases. 37(5). e74–e77. 53 indexed citations
16.
Hadley, Susan, et al.. (2002). Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients. Critical Care Medicine. 30(8). 1808–1814. 37 indexed citations
17.
Hadley, Susan. (2002). Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. 49(2). 415–419. 27 indexed citations
18.
Hadley, Susan & Judith J. Petry. (1999). Medicinal Herbs: A Primer for Primary Care. Hospital Practice. 34(6). 105–123. 19 indexed citations
19.
Pelak, Barbara A., George K. Abruzzo, Robert A. Fromtling, et al.. (1989). L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.. The Journal of Antibiotics. 42(5). 815–822. 3 indexed citations
20.
Pelak, Barbara A., et al.. (1988). L-656,575 (OCP-9-176): A novel oxacephem pharmacokinetics and experimental chemotherapy.. The Journal of Antibiotics. 41(8). 1137–1141. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026